Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 6M - 6M
Notice Type:
Contract award notice
Published Date:
14 September 2020
Closing Date:
Location(s):
FRH01 Côtes-d’Armor (FR FRANCE)
Description:
Fourniture de médicaments de cancérologie — bévacizumab. Période du 1.9.2020 au 31.5.2021, reconductible jusqu'au 31.5.2024

Fourniture de médicaments de cancérologie — bévacizumab. Période du 1.9.2020 au 31.5.2021, reconductible jusqu'au 31.5.2024.


Lot 1 — bévacizumab

Lot 1 — bévacizumab

Awarded to:
Bévacizumab
Pfizer, Paris Cedex 14 (FR)
Download full details as .pdf
The Buyer:
CHG de Saint-Brieuc
CPV Code(s):
33600000 - Pharmaceutical products